Lung cancer researcher, Bryant Kin, has been diagnosed with the disease despite never smoking himself in his life, he's ...

Having an understanding of the progression of lung cancer and the treatment methods helps the patients and their families to ...

A researcher at Stanford University School of Medicine has been diagnosed with stage 4 lung cancer, even though he has never ...

Journal of Thoracic Disease: “Adjuvant or neoadjuvant chemotherapy for NSCLC.” UpToDate: “Patient Information: Non-small cell lung cancer treatment; Stage I to III cancer (Beyond the Basics)." ...

The FDA has approved the drug durvalumab for adults with limited-stage small-cell lung cancer (LS-SCLC) whose disease hasn’t ...

The identification of incidentally explanted lung cancer should not immediately rule out lung transplant in candidates with ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

Discover the latest advancements in small cell lung cancer through Novotech CRO’s in-depth disease analysis. Gain valuable insights into novel therapies, ongoing clinical trials, and future ...

“Early detection can reduce lung cancer death rates by 20% — that’s significant,” Dr. Gorbatov says. “In some cases when we ...

The U.S. Food and Drug Administration has approved AstraZeneca blockbuster drug Imfinzi to treat some adults with ...

The study characterizes the lung cancer tumor microenvironment, linking cellular compositions to immunotherapy resistance and ...

Stanford University School of Medicine clinical professor and researcher Dr. Bryant Lin has been diagnosed with stage 4 lung cancer despite ... with chronic kidney disease, in which the patient ...